|
BOLD Boundless Bio Inc 1782303 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-23,693,000.00 |
| Balance Sheet |
|
Current Assets
|
$73,647,000.00 |
|
Assets
|
$73,744,000.00 |
|
Current Liabilities
|
$7,768,000.00 |
|
Liabilities
|
$7,768,000.00 |
|
Equity
|
$65,976,000.00 |
|
Shares Out
|
22475000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-35,945,000.00 |
|
Investing Cash Flow
|
$37,657,000.00 |
| Market Analysis |
Market Cap
|
$65,177,500.00 |
|
Price
|
$2.90 |
|
BVPS
|
2.94 |
|
PB
|
0.99 |
|
EPS
|
-1.06 |
|
FCF
|
$-35,991,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BOLD documents filed with the SEC.
BOLD Filings
Clear
